Local anesthetics

Clinical Anesthesia: Seventh Edition

Volumn , Issue , 2013, Pages

  Lin, Yi ^a,b   Liu, Spencer S ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84901060070     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (131)

1. Wheater PR, Burkitt HG, Daniels VG. Functional Histology. 2nd ed. New York, NY: Churchill Livingstone; 1987:95.
2. Ritchie JM, Ritchie B, Greengard P. The effect of the nerve sheath on the action of local anesthetics. J Pharmacol Exp Ther. 1965;150:160.
3. Coggeshall RE. A fine structural analysis of the myelin sheath in rat spinal roots. Anat Rec. 1979;194:201.
4. Waxman SG, Ritchie JM. Organization of ion channels in the myelinated nerve fiber. Science. 1985;228:1502.
5. Koester J. Passive membrane properties of the neuron. In: Kandel ER, Schwartz JH, Jessell TM. Principles of Neuroscience. 3rd ed. New York, NY: Elsevier Science; 1991.
6. Hodgkin AL, Katz B. The effect of sodium ions on the electrical activity of the giant axon of the squid. J Physiol. 1949;108:37.
7. Hodgkin AL, Huxley AF. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol. 1952;117:500.
8. Sigworth FJ, Neher E. Single Na+ channel currents observed in cultured rat muscle cells. Nature. 1980;287:447.
9. Catterall WA. From ionic currents to molecular mechanisms: The structure and function of voltage-gated sodium channels. Neuron. 2000;26:13.
10. Hirschberg B, Rovner A, Lieberman M, et al. Transfer of twelve charges is needed to open skeletal muscle Na+ channels. J Gen Physiol. 1995;106:1053.
11. Heinemann SH, Terlau H, Stühmer W, et al. Calcium channel characteristics conferred on the sodium channel by single mutations. Nature. 1992;356:441.
12. Armstrong CM. Sodium channels and gating currents. Physiol Rev. 1981;61:644.
13. Stühmer W, Conti F, Suzuki H, et al. Structural parts involved in activation and inactivation of the sodium channel. Nature. 1989;339:597.
14. West JW, Patton DE, Scheuer T, et al. A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation. Proc Natl Acad Sci USA. 1992;89:10910.
15. Woods JN, Boorman JP, Okuse K, et al. Voltage-gated sodium channels and pain pathways. J Neurobiol. 2004;61:55.
16. Drenth JP, te Morsche RH, Guillet G, et al. SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol. 2005;124:1333.
17. Fertleman CR, Baker MD, Parker KA, et al. SCN9A mutations in paroxysmal extreme pain disorder: Allelic variants underlie distinct channel defects and phenotypes. Neuron. 2006;52:767.
18. Cox JJ, Reimann F, Nicholas AK, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature. 2006;444:894.
19. Goldberg Y, Macfarlane J, Macdonald M, et al. Loss-of-function mutations in the Na(v) 1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet. 2007;71:311.
20. Frazier DT, Narahashi T, Yamada M. The site of action and active form of local anesthetics. II. Experiments with quaternary compounds. J Pharmacol Exp Ther. 1970;171:45.
21. Ragsdale DS, McPhee JC, Scheuer T, et al. Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science. 1994;265:1724.
22. Scholz A. Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels. Br J Anaesth. 2002;89:52.
23. Ulbricht W. Sodium channel inactivation: Molecular determinants and modulation. Physiol Rev. 2005;85:1271.
24. Popitz-Bergez FA, Leeson S, Strichartz GR, et al. Relation between functional deficit and intraneural local anesthetic during peripheral nerve block. A study in the rat sciatic nerve. Anesthesiology. 1995;83:583.
25. Fink BR, Cairns AM. Differential slowing and block of conduction by lidocaine in individual afferent myelinated and unmyelinated axons. Anesthesiology. 1984;60:111.
26. Fink BR, Cairns AM. Differential use-dependent (frequency-dependent) effects in single mammalian axons: Data and clinical considerations. Anesthesiology. 1987;67:477.
27. Fink BR. Mechanisms of differential axial blockade in epidural and subarachnoid anesthesia. Anesthesiology. 1989;70:851.
28. Gasser HS, Erlanger J. The role of fiber size in the establishment of a nerve block by pressure or cocaine. Am J Physiol. 1929;88:581.
29. Gokin AP, Philip B, Strichartz GR. Preferential block of small myelinated sensory and motor fibers by lidocaine: In vivo electrophysiology in the rat sciatic nerve. Anesthesiology. 2001;95:1441.
30. Chevrier P, Vijayaragavan K, Chahine M. Differential modulation of Nav 1.7 and Nav 1.8 peripheral nerve sodium channels by the local anesthetic lidocaine. Br J Pharmacol. 2004;142:576.
31. Chernoff DM, Strichartz GR. Tonic and phasic block of neuronal sodium currents by 5-hydroxyhexano-2',6'-xylide, a neutral lidocaine homologue. J Gen Physiol. 1989:93:1075.
32. a values of clinically used drugs. Anesth Analg. 1990;71:158.
33. Bokesch PM, Post C, Strichartz G. Structure-activity relationship of lidocaine homologs producing tonic and frequency-dependent impulse blockade in nerve. J Pharmacol Exp Ther. 1986;237:773.
34. Gissen AJ, Covino BG, Gregus J. Differential sensitivity of fast and slow fibers in mammalian nerve. III. Effect of etidocaine and bupivacaine on fast/slow fibers. Anesth Analg. 1982;61:570.
35. Johns RA, DiFazio CA, Longnecker DE. Lidocaine constricts or dilates rat arterioles in a dose-dependent manner. Anesthesiology. 1985;62:141.
36. Johns RA, Seyde WC, DiFazio CA, et al. Dose-dependent effects of bupivacaine on rat muscle arterioles. Anesthesiology. 1986;65:186.
37. Foster RH, Markham A. Levobupivacaine: A review of its pharmacology and use as a local anaesthetic. Drugs. 2000;59:551.
38. McClellan KJ, Faulds D. Ropivacaine: An update of its use in regional anaesthesia. Drugs. 2000;60:1065.
39. Neal JM. Effects of epinephrine in local anesthetics on the central and peripheral nervous systems: Neurotoxicity and neural blood flow. Reg Anesth Pain Med. 2003;28:124.
40. Sinnott CJ, Cogswell III LP, Johnson A, et al. On the mechanism by which epinephrine potentiates lidocaine's peripheral nerve block. Anesthesiology. 2003; 98:181.
41. Curatolo M, Petersen-Felix S, Arendt-Nielsen L, et al. Epidural epinephrine and clonidine: Segmental analgesia and effects on different pain modalities. Anesthesiology. 1997;87:785.
42. Ueda W, Hirakawa M, Mori K. Acceleration of epinephrine absorption by lidocaine. Anesthesiology. 1985;63:717.
43. Magee C, Rodeheaver GT, Edgerton MT, et al. Studies of the mechanisms by which epinephrine damages tissue defenses. J Surg Res. 1977;23:126.
44. Hall JA, Ferro A. Myocardial ischaemia and ventricular arrhythmias precipitated by physiological concentrations of adrenaline in patients with coronary artery disease. Br Heart J. 1992;67:419.
45. Lambert DH. Clinical value of adding sodium bicarbonate to local anesthetics. Reg Anesth Pain Med. 2002;27:328.
46. Ikuta PT, Raza SM, Durrani Z. pH adjustment schedule for the amide local anesthetics. Reg Anesth. 1989;14:229.
47. Neal JM, Hebl JR, Gerancher JC, et al. Brachial plexus anesthesia: Essentials of our current understanding. Reg Anesth Pain Med. 2002;27:402.
48. Sinnott CJ, Garfield JM, Thalhammer JG. Addition of sodium bicarbonate to lidocaine decreases the duration of peripheral nerve block in the rat. Anesthesiology. 2000;93:1045.
49. Wang C, Chakrabarti MK, Galletly DC, et al. Relative effects of intrathecal administration of fentanyl and midazolam on A delta and C fibre reflexes. Neuropharmacology. 1992;31:439.
50. Niv D, Nemirovsky A, Rudick V. Antinociception induced by simultaneous intrathecal and intraperitoneal administration of low doses of morphine. Anesth Analg. 1995;80:886.
51. Walker SM, Goudas LC, Cousins MJ, et al. Combination spinal analgesic chemotherapy: A systematic review. Anesth Analg. 2002;95:674.
52. Karambelkar DJ, Ramanathan S. 2-chloroprocaine antagonism of epidural morphine analgesia. Acta Anaesth Scand. 1997;41:774.
53. Coda B, Bausch S, Haas M, et al. The hypothesis that antagonism of fentanyl analgesia by 2-chloroprocaine is mediated by direct action on opioid receptors. Reg Anesth. 1997;22:43.
54. Janson W, Stein C. Peripheral opioid analgesia. Curr Pharm Biotechnol. 2003; 4:270.
55. Picard PR, Tramer MR, McQuay HJ, et al. Analgesic efficacy of peripheral opioids (all except intra-articular): A qualitative systematic review of randomised controlled trials. Pain. 1997;72:309.
56. Candido KD, Winnie AP, Ghaleb AH, et al. Buprenorphine added to the local anesthetic for axillary brachial plexus block prolongs postoperative analgesia. Reg Anesth Pain Med. 2002;27:162.
57. Candido KD, Hennes J, Gonzalez S, et al. Buprenorphine enhances and prolongs the postoperative analgesic effect of bupivacaine in patients receiving infragluteal sciatic nerve block. Anesthesiology. 2010;113:419.
58. Rosseland LA. No evidence for analgesic effect of intra-articular morphine after knee arthroscopy: A qualitative systematic review. Reg Anesth Pain Med. 2005;30:83.
59. Eisenach JC, De Kock M, Klimscha W. Alpha(2)-adrenergic agonists for regional anesthesia: A clinical review of clonidine (1984-1995). Anesthesiology. 1996;85: 655.
60. 2-adrenergic agonists clonidine and guanfacine produce tonic and phasic block of conduction in rat sciatic nerve fibers. Anesth Analg. 1993;76:295.
61. Gaumann DM, Brunet PC, Jirounek P. Clonidine enhances the effects of lidocaine on C fiber action potential. Anesth Analg. 1992;74:719.
62. 2-adrenoreceptor agonist and cocaine in the rat. Anesth Analg. 1994;79:261.
63. Popping DM, Elia N, Marret, et al. Clonidine as an adjuvant to local anesthetics for peripheral nerve and plexus blocks. Anesthesiology. 2009;111:406.
64. Colin JL, McCartney ED, Apatu E. Should we add clonidine to local anesthetic for peripheral nerve blockade? A qualitative systematic review of the literature. Reg Anesth Pain Med. 2007;32:330.
65. Curley J, Castillo J, Hotz J, et al. Prolonged regional nerve blockade: Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology. 1996;84:140.
66. Drager C, Benziger D, Gao F, et al. Prolonged intercostal nerve blockade in sheep using controlled-release of bupivacaine and dexamethasone from polymer microspheres. Anesthesiology. 1998;89:969.
67. Castillo J, Curley J, Hotz, et al. Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres. Anesthesiology. 1996;85:1157.
68. Parrington SJ, O'Donnell DO, Chan V, et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus blockade. Reg Anesth Pain Med. 2010;35:422.
69. Cummings KC, Napierkowski DE, Parra-Sanchez I, et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. Br J Anaesth. 2011;107:446.
70. Bigat Z, Boztug N, Hadimioglu N, et al. Does dexamethasone improve the quality of intravenous regional anesthesia and analgesia? A randomized, controlled clinical study. Anesth Analg. 2006;102:605.
71. Williams BA, Hough KA, Tsui B, et al. Neurotoxicity of adjuvants used in perineural anesthesia and analgesia in comparison with ropivacaine. Reg Anesth Pain Med. 2011;36:225.
72. Morrison LM, Emanuelsson BM, McClure JH, et al. Efficacy and kinetics of extradural ropivacaine: Comparison with bupivacaine. Br J Anaesth. 1994;72:164.
73. Tucker GT, Mather LE. Pharmacology of local anaesthetic agents. Pharmacokinetics of local anaesthetic agents. Br J Anaesth. 1975;47(suppl):213.
74. Thomson PD, Melmon KL, Richardson JA, et al. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann Intern Med. 1973;78:499.
75. Rosenberg PR, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: A multifactorial concept. Reg Anesth Pain Med. 2004;29:564.
76. Braid DP, Scott DB. Dosage of lignocaine in epidural block in relation to toxicity. Br J Anaesth. 1996;38:596.
77. Adinoff B, Devous Sr MD, Best SE, et al. Gender differences in limbic responsiveness, by SPECT, following pharmacologic challenge in healthy subjects. Neuroimage. 2003;18:697.
78. Tucker GT, Mather LE. Properties, absorption, and disposition of local anesthetic agents. In: Cousins MJ, Bridenbaugh PO, eds. Neural Blockade in Clinical Anesthesia and Management of Pain. 3rd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1998:55.
79. Lander JA, Weltman BJ, So SS. EMLA and amethocaine for reduction of children's pain associated with needle insertion. Cochrane Database Syst Rev. 2006;3: CD004236.
80. Ugur B, Ogurlu M, Gezer E, et al. Effects of esmolol, lidocaine and fentanyl on haemodynamic responses to endotracheal intubation. A comparative study. Clin Drug Investig. 2007;27:269.
81. Adamzik M, Groeben H, Farahani R, et al. Intravenous lidocaine after tracheal intubation mitigates bronchoconstriction in patients with asthma. Anesth Analg. 2007;104:168.
82. Groban L. Central nervous system and cardiac effects from long-acting amide local anesthetic toxicity in the intact animal model. Reg Anesth Pain Med. 2003; 28:3.
83. Weinberg GL. Current concepts in resuscitation of patients with local anesthetic cardiac toxicity. Reg Anesth Pain Med. 2002;27:568.
84. Brown DL, Ransom DM, Hall JA, et al. Regional anesthesia and local anesthetic-induced systemic toxicity: Seizure frequency and accompanying cardiovascular changes. Anesth Analg. 1995;81:321.
85. Auroy Y, Benhamou D, Bargues L, et al. Major complications of regional anesthesia in France: The SOS Regional Anesthesia Hotline Service. Anesthesiology. 2002;97:1274.
86. Lee LA, Posner KL, Domino KB, et al. Injuries associated with regional anesthesia in the 1980s and 1990s: A closed claim analysis. Anesthesiology. 2004;101:143.
87. Butterworth JF. Models and mechanisms of local anesthetic cardiac toxicity. Reg Anesth Pain Med. 2010;35:167.
88. Mather LE, Copeland SE, Ladd LA. Acute toxicity of local anesthetics: Underlying pharmacokinetic and pharmacodynamic concepts. Reg Anesth Pain Med. 2005;30:553.
89. Knudsen K, Beckman Suurkula M, Blomberg S, et al. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507.
90. Stewart J, Kellett N, Castro D. The central nervous system and cardiovascular effects of levobupivacaine and ropivacaine in healthy volunteers. Anesth Analg. 2002;97:412.
91. Vanhoutte F, Vereecke J, Verbeke N, et al. Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guinea-pig papillary muscle. Br J Pharmacol. 1991;103:1275.
92. Valenzuela C, Snyders D, Bennett PB, et al. Stereoselective block of sodium channels by bupivacaine in guinea pig ventricular myocytes. Circulation. 1995;92:3014.
93. Groban L, Deal DD, Vernon JC, et al. Does local anesthetic stereoselectivity or structure predict myocardial depression in anesthetized canines? Reg Anesth Pain Med. 2002;27:460.
94. Pickering AE, Waki H, Headley PM, et al. Investigation of systemic bupivacaine toxicity using the in situ perfused working heart-brainstem preparation of the rat. Anesthesiology. 2002;97:1550.
95. Chang KSK, Yang M, Andresen MC. Clinically relevant concentrations of bupivacaine inhibit rat aortic baroreceptors. Anesth Analg. 1994;78:501.
96. Newton DJ, McLeod GA, Khan F, et al. Vasoactive characteristics of bupivacaine and levobupivacaine with and without adjuvant epinephrine in peripheral human skin. Br J Anaesth. 2005;94:662.
97. Liu P, Feldman HS, Covina BM, et al. Acute cardiovascular toxicity of intravenous amide local anesthetics in anesthetized ventilated dogs. Anesth Analg. 1982;61:317.
98. Guo XT, Castle NA, Chernoff DM, et al. Comparative inhibition of voltage-gated cation channels by local anesthetics. Ann N Y Acad Sci. 1991;625:181.
99. Clarkson CW, Hondegham LM. Mechanisms for bupivacaine depression of cardiac conduction: Fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology. 1985;62:396.
100. Nouette-Gaulain K, Forestier F, Malgat M, et al. Effects of bupivacaine on mitochondrial energy metabolism in heart of rats following exposure to chronic hypoxia. Anesthesiology. 2002;97:1507.
101. Wong GK, Crawford MW. Carnitine deficiency increases susceptibility to bupivacaine-induced cardiotoxicity in rats. Anesthesiology. 2011;114:1417.
102. Weinberg GL. Treatment of local anesthetic systemic toxicity (LAST). Reg Anesth Pain Med. 2010;35:188.
103. Long WB, Rosenblum S, Grady IP. Successful resuscitation of bupivacaine-induced cardiac arrest using cardiopulmonary bypass. Anesth Analg. 1989;79:403.
104. Soltesz EG, van Pelt F, Byrne JG. Emergent cardiopulmonary bypass for bupivacaine cardiotoxicity. J Cardiothorac Vasc Anesth. 2003;17:357.
105. Weinberg GL, VadeBoncouer T, Ramaraju GA, et al. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology. 1998;99:1071.
106. Weinberg GL, Ripper R, Feinstein DL, et al. Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med. 2003;28:198.
107. Rosenblatt MA, Abel M, Fischer GW, et al. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology. 2006;105:217.
108. Litz RJ, Popp M, Stehr SN, et al. Successful resuscitation of a patient with ropivacaine-induced asystole after axillary plexus block using lipid infusion. Anaesthesia. 2006;61:800.
109. Weinberg GL, Ripper R, Murphy P, et al. Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart. Reg Anesth Pain Med. 2006;31:296.
110. Weinberg GL, Palmer JW, VadeBoncouer TR, et al. Bupivacaine inhibits acylcarnitine exchange in cardiac mitochondria. Anesthesiology. 2000;92:523.
111. Kitagawa N, Oda M, Totoki T. Possible mechanism of irreversible nerve injury caused by local anesthetics and membrane disruption. Anesthesiology. 2004;100:962.
112. Kalichman MW. Physiologic mechanisms by which local anesthetics may cause injury to nerve and spinal cord. Reg Anesth. 1993;18:448.
113. Whitlock EL, Brenner MJ, Fox IK, et al. Ropivacaine-induced peripheral nerve injection injury in the rodent model. Anesth Analg. 2010;111:214.
114. Selander D. Neurotoxicity of local anesthetics: Animal data. Reg Anesth. 1993; 18:461.
115. Kroin JS, Buvanendran A, Williams DK, et al. Local anesthetic sciatic nerve block and nerve fiber damage in diabetic rats. Reg Anesth Pain Med. 2010;35:343.
116. Brull R, McCartney CJL, Chan VWS, et al. Neurological complications after regional anesthesia: Contemporary estimates of risk. Anesth Analg. 2007;104:965.
117. Bigeleisen PE. Nerve puncture and apparent intraneural injection during ultrasound-guided axillary block does not invariably result in neurologic injury. Anesthesiology. 2006;105:779.
118. Rigler M, Drasner K, Krejcie T, et al. Cauda equina syndrome after continuous spinal anesthesia. Anesth Analg. 1991;72:275.
119. Reisner L, Hochman B, Plumer M. Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chloroprocaine injection. Anesth Analg. 1980; 58:452.
120. Pollock JE. Transient neurologic symptoms: Etiology, risk factors, and management. Reg Anesth Pain Med. 2002;27:581.
121. Zaric D, Christiansen C, Pace NL, et al. Transient neurologic symptoms after spinal anesthesia with lidocaine versus other local anesthetics: A systematic review of randomized, controlled trials. Anesth Analg. 2005;100:1811.
122. Pollock JE, Liu SS, Neal JM, et al. Dilution of lidocaine does not decrease the incidence of transient neurologic symptoms. Anesthesiology. 1999;90:445.
123. Hogan Q, Dotson R, Erickson S, et al. Local anesthetic myotoxicity: A case and review. Anesthesiology. 1994;80:942.
124. Zink W, Bohl JRE, Hacke N, et al. The long term myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blocks. Anesth Analg. 2005;101:548.
125. Nouette-Gaulain K, Dadure C, Morau D, et al. Age-dependent bupivacaine-induced muscle toxicity during continuous peripheral nerve block in rats. Anesthesiology. 2009;111:1120.
126. Nouette-Gaulain K, Sirvent P, Canal-Raffin M, et al. Effects of intermittent femoral nerve injections of bupivacaine, levobupivacaine, and ropivacaine on mitochondrial energy metabolism and intracellular calcium homeostasis in rat psoas muscle. Anesthesiology. 2007;106:1026.
127. Nouette-Gaulain K, Bellance N, Prevost B, et al. Erythropoietin protects against local anesthetic myotoxicity during continuous regional anesthesia. Anesthesiology. 2009;110:648.
128. Galbes O, Bourret A, Nouette-Gaulain K, et al. N-acetylcysteine protects against bupivacaine-induced myotoxicity caused by oxidative and sarcoplasmic reticulum stress in human skeletal myotubes. Anesthesiology. 2010;113:560.
129. Boren E, Teuber SS, Naguwa SM, et al. A critical review of local anesthetic sensitivity. Clin Rev Allergy Immunol. 2007;32:119.
130. Phillips JF, Yates AB, Deshazo RD. Approach to patients with suspected hypersensitivity to local anesthetics. Am J Med Sci. 2007;334:190.
131. McClimon B, Rank M, Li J. The predictive value of skin testing in the diagnosis of local anesthetic allergy. Allergy Asthma Proc. 2011;32:95.